Toggle navigation
Home
Search
Services
Blog
Contact
About
1/2 Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia (HHT)
McCrae, Keith R.
Cleveland Clinic Lerner, Cleveland, OH, United States
Search 57 grants from Keith McCrae
Search grants from Cleveland Clinic Lerner
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Chemical Probes for Type III Protein Secretion in Bacterial Pathogens
Nicotinic Synaptic Mechanisms in Chick Ciliary Ganglion
Mapping Idiopathic Epilepsy Genes in Canine Models
Improving Adherence to Interventions for Hypertension
Biomedical Research Support
Recently added grants:
Inhibiting extracellular Hsp90 to reduce breast cancer metastasis
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
How does malignancy subvert platelet and megakaryocytic biology?
Dietary control of stem cells in physiology and cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Cooperative Agreement Phase II (UH3)
Project #
4UH3HL140097-02
Application #
10026357
Study Section
Clinical Trials Review Committee (CLTR)
Program Officer
Kindzelski, Andrei L
Project Start
2020-03-15
Project End
2024-02-29
Budget Start
2020-03-15
Budget End
2021-02-28
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Institution
Name
Cleveland Clinic Lerner
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Comments
Be the first to comment on Keith McCrae's grant